Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

GeneMe, a Poland-based universal molecular genetic tests platform spun out of Institute of Biotechnology and Molecular Medicine, has closed a €5.2m ($6.4m) seed round led by Robin Tombs, with participation from other angel investors, TechCrunch reported yesterday. The spinout’s offering includes three tests for covid-19. GeneMe’s technology can be assembled at the point of care and offers both highly accurate and rapid results.
MaxWell Biosystems, a Switzerland-based spinout of ETH Zürich that is using electrophysiology technology to discover and developer treatments for neurodegenerative diseases, completed a CHF4m ($4.5m) series A round on Wednesday featuring microsensor producer Sensirion Holding. The round included unnamed existing and individual investors, and it came after MaxWell received from winning $100,000 in a Venture Kick contest in 2017.
Purdue University has offered an in-depth look at new spinout Alethia, a US-based provider of visual data analytics technologies. Alethia’s use-cases include combing footage from network cameras in public spaces to observe how people move and behave during the covid-19 pandemic, and their willingness to congregate and spend at retail locations. The product grew from research led by Yung-Hsiang Lu, a professor of electrical and computer engineering at Purdue’s College of Engineering.
– Additional reporting by Thierry Heles and Robert Lavine